Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

Leukemia. 2016 Jun;30(6):1446-8. doi: 10.1038/leu.2015.338. Epub 2015 Dec 9.

Authors

C Pawlyn^{1

2}, L Fowkes³, S Otero³, J R Jones^{1

2}, K D Boyd², F E Davies^{1

4}, G J Morgan^{1

4}, D J Collins⁵, B Sharma³, A Riddell³, M F Kaiser^{1

2}, C Messiou^{1

3}

Affiliations

¹ The Institute of Cancer Research, London, UK.
² Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
³ Department of Radiology, The Royal Marsden Hospital NHS Foundation Trust, London, UK.
⁴ Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
⁵ CRUK Cancer Imaging Centre, The Institute Of Cancer Research, and The Royal Marsden Hospital NHS Foundation Trust, London, UK.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Diffusion Magnetic Resonance Imaging / methods*
Female
Humans
Male
Middle Aged
Multiple Myeloma / diagnostic imaging*
Retrospective Studies
Whole Body Imaging / methods*

Grants and funding